Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FERROUS ANHYDROUS for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where FERROUS ANHYDROUS was used for Maternal exposure timing unspecified.

Most Reported Side Effects for FERROUS ANHYDROUS

Side Effect Reports % Deaths Hosp.
Asthma 190 38.5% 13 95
Full blood count abnormal 160 32.4% 13 79
Gastrooesophageal reflux disease 151 30.6% 0 56
Dyspnoea 106 21.5% 13 105
Wheezing 103 20.9% 11 102
Hyperglycaemia 95 19.2% 0 0
Type 2 diabetes mellitus 95 19.2% 0 0
Obstructive airways disorder 83 16.8% 13 83
Sleep disorder due to a general medical condition 81 16.4% 12 81
Therapeutic product effect incomplete 75 15.2% 11 75
Foetal exposure during pregnancy 74 15.0% 6 19
Condition aggravated 70 14.2% 13 70
Rhinorrhoea 69 14.0% 0 69
Chronic obstructive pulmonary disease 66 13.4% 0 66
Secretion discharge 65 13.2% 0 65

Other Indications for FERROUS ANHYDROUS

Product used for unknown indication (377) Supplementation therapy (30) Anaemia (28) Hiv infection (17) Foetal exposure during pregnancy (16)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

FERROUS ANHYDROUS Full Profile All Maternal exposure timing unspecified Drugs FERROUS ANHYDROUS Demographics FERROUS ANHYDROUS Timeline